灵霉素
断开
心理学
心理治疗师
临床心理学
萧条(经济学)
抗抑郁药
精神科
抑郁症状
感知
致幻剂
认知
焦虑
法学
神经科学
经济
宏观经济学
政治学
作者
Rosalind Watts,Camilla Day,Jacob Krzanowski,David Nutt,Robin Carhart‐Harris
标识
DOI:10.1177/0022167817709585
摘要
Objective: To identify patients’ perceptions of the value of psilocybin as a treatment for depression. Method: Twenty patients enrolled in an open-label trial of psilocybin for treatment-resistant depression participated in a semistructured interview at 6-month follow-up. Thematic analysis was used to identify patients’ experiences of the treatment and how it compared with previous treatments. Results: Two main change processes were identified in relation to the treatment. The first concerned change from disconnection (from self, others, and world) to connection, and the second concerned change from avoidance (of emotion) to acceptance. A third theme concerned comparison between psilocybin and conventional treatments. Patients reported that medications and some short-term talking therapies tended to reinforce their sense of disconnection and avoidance, whereas treatment with psilocybin encouraged connection and acceptance. Conclusions: These results suggest that psilocybin treatment for depression may work via paradigmatically novel means, antithetical to antidepressant medications, and some short-term talking therapies.
科研通智能强力驱动
Strongly Powered by AbleSci AI